Lene Surland Knudsen

Lene Surland Knudsen serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. Her clinical work is situated within the Internal Medicine specialization focusing on infection medicine, with her institutional affiliation extending to Region Sjælland healthcare system as indicated by her professional email domain.

Dr. Knudsen's research interests center on infectious disease immunology with particular emphasis on SARS-CoV-2 and vaccine responses. Her work explores antibody kinetics, viral variant interactions, and vaccine efficacy across diverse populations including elderly patients with comorbidities and pregnant women. She investigates how immune responses develop and wane following vaccination and natural infection, with special attention to hybrid immunity scenarios.

Analysis of her recent publications reveals a consistent focus on population-level vaccine studies, particularly through the Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE). Her research spans immunological mechanisms, clinical outcomes, and public health implications of vaccination strategies against emerging variants. Much of her work employs large-scale epidemiological approaches combined with detailed immunological measurements.

Dr. Knudsen actively contributes to major collaborative research initiatives, most notably as a key member of the ENFORCE study group and the ACTIV-3/TICO clinical trial consortium. Her work has attracted significant attention, with multiple publications covered by news outlets, referenced in clinical guidelines, and discussed across social media platforms with substantial readership on academic networks like Mendeley.

Her laboratory and research activities appear to be integrated within the Department of Clinical Medicine's infection medicine division, working closely with regional healthcare providers through Region Sjælland. The ENFORCE study represents a major focus of her current research program, examining vaccine effectiveness and safety in real-world settings across Denmark.